Novel indole derivatives as selective androgen receptor modulators (SARMS)

Details for Australian Patent Application No. 2005243238 (hide)

Owner Janssen Pharmaceutica N.V.

Inventors Lanter, James C.; Zhang, Xuqing; Fiordeliso, James J.; Jiang, Weiqin; Sui, Zhihua

Agent Shelston IP

Pub. Number AU-B-2005243238

PCT Pub. Number WO2005/111042

Priority 60/567,717 03.05.04 US

Filing date 1 April 2005

Wipo publication date 24 November 2005

Acceptance publication date 10 November 2011

International Classifications

C07D 487/04 (2006.01) Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups

A61K 31/437 (2006.01)

Event Publications

16 November 2006 PCT application entered the National Phase

  PCT publication WO2005/111042 Priority application(s): WO2005/111042

10 November 2011 Application Accepted

  Published as AU-B-2005243238

8 March 2012 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2005243239-Indole, benzofuran and benzothiophene derivatives as selective androgen receptor modulators (SARMS)

2005243233-Method of operating a wormgear drive at high energy efficiency